Published on in Vol 6 , No 7 (2022) :July
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/34248, first published
.

Journals
- Röth A, Broome C, Barcellini W, Jilma B, Hill Q, Cella D, Tvedt T, Yamaguchi M, Lee M, Shafer F, Wardęcki M, Jiang X, Patel P, Joly F, Weitz I. Sutimlimab provides clinically meaningful improvements in patient‐reported outcomes in patients with cold agglutinin disease: Results from the randomised, placebo‐controlled, Phase 3 CADENZA study. European Journal of Haematology 2023;110(3):280 View